05/28/2021 | Press release | Distributed by Public on 05/28/2021 11:19
IFC, Proparco, and Cerba Lancet Africa Partner to Expand Diagnostic Capacity, Support COVID-19 Response in Africa
Johannesburg, South Africa, May 28, 2021-To strengthen diagnostic capacity and the health response to COVID-19 in Africa, including in some of the continent's poorest and most fragile countries, IFC, Proparco, and Cerba Lancet Africa today announced a partnership to increase patient access to a range of laboratory tests.
Expanding access to diagnostics and laboratory testing is a critical part of tackling COVID-19, which has exposed vulnerabilities in health systems across Africa and the need for increased testing and laboratory services.